Partnering With Patient Advocacy Groups Benefits Pharma And Patients

A vital conduit between pharma companies and potential patient recruits, patient advocacy groups (PAGs) fulfill various roles, such as providing material resources, knowledge, and emotional support to those in need. Partnerships between PAGs and pharma companies can be mutually beneficial and lead to positive health outcomes for patients. For example, clinical trials can adopt a more patient-centric approach with the help of PAGs, and trial managers can recruit patients more effectively.

Despite being around since the 1950s, however, PAGs have undergone criticism surrounding their relationships with healthcare entities when it comes to questions of financial donations and the group’s subsequent independence. If built on trust and transparency, all parties involved will always put the patient first.

Explore why pharmaceutical companies should build relationships with PAGs, how to make these partnerships mutually beneficial, and jettison criticisms of lost independence.